These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15982325)

  • 21. High WT1 expression is associated with very poor survival of patients with osteogenic sarcoma metastasis.
    Srivastava A; Fuchs B; Zhang K; Ruan M; Halder C; Mahlum E; Weber K; Bolander ME; Sarkar G
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4237-43. PubMed ID: 16857797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. WT1 interacts with the splicing protein RBM4 and regulates its ability to modulate alternative splicing in vivo.
    Markus MA; Heinrich B; Raitskin O; Adams DJ; Mangs H; Goy C; Ladomery M; Sperling R; Stamm S; Morris BJ
    Exp Cell Res; 2006 Oct; 312(17):3379-88. PubMed ID: 16934801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of anti-thrombomodulin antibody as a tumor marker for vascular neoplasms.
    Manning T; Smoller BR; Horn TD; El Darouti M; Marzouk S; Hadidi HE; Ramadan S
    J Cutan Pathol; 2004 Nov; 31(10):652-6. PubMed ID: 15491324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human endothelial cells inhibit BMSC differentiation into mature osteoblasts in vitro by interfering with osterix expression.
    Meury T; Verrier S; Alini M
    J Cell Biochem; 2006 Jul; 98(4):992-1006. PubMed ID: 16479590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA-binding dependent and independent functions of WT1 protein during human hematopoiesis.
    Svensson E; Eriksson H; Gekas C; Olofsson T; Richter J; Gullberg U
    Exp Cell Res; 2005 Aug; 308(1):211-21. PubMed ID: 15907324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wilms' tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro.
    Jomgeow T; Oji Y; Tsuji N; Ikeda Y; Ito K; Tsuda A; Nakazawa T; Tatsumi N; Sakaguchi N; Takashima S; Shirakata T; Nishida S; Hosen N; Kawakami M; Tsuboi A; Oka Y; Itoh K; Sugiyama H
    Cancer Sci; 2006 Apr; 97(4):259-70. PubMed ID: 16630117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells.
    Reizner N; Maor S; Sarfstein R; Abramovitch S; Welshons WV; Curran EM; Lee AV; Werner H
    J Mol Endocrinol; 2005 Aug; 35(1):135-44. PubMed ID: 16087727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression of WT1 gene and its isomer ratio changes during phorbol ester induced differentiation of K562 cell line].
    Li XH; Wang HW; Li JL; Zhu L; Fan WP; Tian CX; Xu J; Xu YQ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jun; 28(6):367-70. PubMed ID: 17939399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A cell-autonomous role for WT1 in regulating Sry in vivo.
    Bradford ST; Wilhelm D; Bandiera R; Vidal V; Schedl A; Koopman P
    Hum Mol Genet; 2009 Sep; 18(18):3429-38. PubMed ID: 19549635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new molecular variant of desmoplastic small round cell tumor: significance of WT1 immunostaining in this entity.
    Murphy AJ; Bishop K; Pereira C; Chilton-MacNeill S; Ho M; Zielenska M; Thorner PS
    Hum Pathol; 2008 Dec; 39(12):1763-70. PubMed ID: 18703217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Wilms' tumor suppressor Wt1 is associated with the differentiation of retinoblastoma cells.
    Wagner N; Wagner KD; Schley G; Coupland SE; Heimann H; Grantyn R; Scholz H
    Cell Growth Differ; 2002 Jul; 13(7):297-305. PubMed ID: 12133898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Elimination of leukemic CD34+ progenitor cells by using cytotoxic T lymphocytes specifically targeting WT1-derived peptide: an experimental study in vitro].
    Gu WY; Chen ZX; Qiu GQ; Hu SY; Jia L; Wu W; He J; Cen JN; He B
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3401-6. PubMed ID: 19159569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hobnail hemangiomas (targetoid hemosiderotic hemangiomas) are true lymphangiomas.
    Franke FE; Steger K; Marks A; Kutzner H; Mentzel T
    J Cutan Pathol; 2004 May; 31(5):362-7. PubMed ID: 15059220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Marsupial WT1 has a novel isoform and is expressed in both somatic and germ cells in the developing ovary and testis.
    Pask AJ; Paplinska JZ; Shaw G; Graves JA; Renfree MB
    Sex Dev; 2007; 1(3):169-80. PubMed ID: 18391528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
    Han Y; San-Marina S; Yang L; Khoury H; Minden MD
    Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. WT1 as a complementary marker of malignant melanoma: an immunohistochemical study of whole sections.
    Wilsher M; Cheerala B
    Histopathology; 2007 Nov; 51(5):605-10. PubMed ID: 17927581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulated expression of the alpha isoform of the human thromboxane A2 receptor during megakaryocyte differentiation: a coordinated role for WT1, Egr1, and Sp1.
    Gannon AM; Turner EC; Reid HM; Kinsella BT
    J Mol Biol; 2009 Nov; 394(1):29-45. PubMed ID: 19747485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Wilms' tumour suppressor WT1 is involved in endothelial cell proliferation and migration: expression in tumour vessels in vivo.
    Wagner N; Michiels JF; Schedl A; Wagner KD
    Oncogene; 2008 Jun; 27(26):3662-72. PubMed ID: 18212735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wilms' tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cells.
    Glienke W; Maute L; Wicht J; Bergmann L
    Eur J Cancer; 2009 Mar; 45(5):874-80. PubMed ID: 19196508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Definition of the features of acquired elastotic hemangioma reporting the clinical and histopathological characteristics of 14 patients.
    Martorell-Calatayud A; Balmer N; Sanmartín O; Díaz-Recuero JL; Sangueza OP
    J Cutan Pathol; 2010 Apr; 37(4):460-4. PubMed ID: 19615005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.